ITW
45
2
EIX
61
8
FAST
41
7
HAS
29
3
INTU
54
2
SWK
53
4
MRK
25
2
JCI
44
7
JNPR
59
3
PCG
59
9
EMN
40
5
MCO
67
3
PEP
33
4
BEN
36
4
ZTS
38
4
NTRS
35
10
PFE
37
4
STT
48
4
MMC
46
5
CF
47
5
ITW
45
2
EIX
61
8
FAST
41
7
HAS
29
3
INTU
54
2
SWK
53
4
MRK
25
2
JCI
44
7
JNPR
59
3
PCG
59
9
EMN
40
5
MCO
67
3
PEP
33
4
BEN
36
4
ZTS
38
4
NTRS
35
10
PFE
37
4
STT
48
4
MMC
46
5
CF
47
5
Financhill
Back

Paycom Software 10K Form

Sell
17

PAYC
Paycom Software

Last Price:
$206.90
Seasonality Move:
5.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PAYC News And Ratings

See the #1 stock for the next 7 days that we like better than PAYC

PAYC Financial Statistics

Sales & Book Value

Annual Sales: $1.7B
Cash Flow: $44.6M
Price / Cash Flow: 38.52
Annual Sales: $26.21
Price / Book: 8.16

Profitability

EPS (TTM): 8.31000
Net Income (TTM): $470.2M
Gross Margin: $1.4B
Return on Equity: 33.33%
Return on Assets: 11.42%

Paycom Software Earnings Forecast

Key Paycom Software Financial Ratios

  • The Gross Profit Margin over the past 13 years for PAYC is 83.69%.
  • The Selling, General & Administrative Expenses for PAYC have been equal to 41.67% of Gross Profit Margin.
  • The Research & Development expenses have been 11.75% of Revenue.
  • The Interest Expense is 0.57% of Operating Income.
  • The Net Earning history of PAYC is 20.12% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 10 years.

Paycom Software Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Professional Services
Sector: Industrials
Current Symbol: PAYC
CUSIP: 70432V
Website: paycom.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.19
Quick Ratio: 0.21

Price-to-Earnings

Trailing P/E Ratio: 35.24
Forward P/E Ratio: 23.73

PAYC Technical Analysis vs Fundamental Analysis

Sell
17
Paycom Software (PAYC) is a Sell

Is Paycom Software a Buy or a Sell?

  • Paycom Software stock is rated a Sell
    The current Paycom Software [PAYC] share price is $207.23. The Score for PAYC is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.